TSCAN THERAPEUTICS INC

Ticker: TCRX CUSIP: 89854M101 Class: Common Stock

Propel Bio Management, LLC's Holding History (CIK: 0001969764)

Note: Option positions (PUT/CALL) are excluded.

Q3 2025
Shares 1,932,304 Value ($000) $3,517 Avg Close $1.77 Range $1.43 - $1.99
Q2 2025
Shares 2,087,139 Value ($000) $3,026 Avg Close $1.44 Range $1.02 - $1.87
Q1 2025
Shares 2,087,139 Value ($000) $2,880 Avg Close $2.16 Range $1.28 - $3.21
Q4 2024
Shares 2,087,139 Value ($000) $6,345 Avg Close $4.53 Range $2.60 - $6.22
Q3 2024
Shares 2,087,139 Value ($000) $10,394 Avg Close $6.03 Range $4.90 - $7.89
Q2 2024
Shares 2,087,139 Value ($000) $12,210 Avg Close $7.88 Range $5.60 - $9.69
Q1 2024
Shares 2,087,139 Value ($000) $16,572 Avg Close $6.29 Range $4.64 - $9.00
Q4 2023
Shares 2,087,139 Value ($000) $12,168 Avg Close $4.58 Range $2.43 - $7.15